Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer Meeting Abstract


Authors: Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; Fasano, J.; Gajria, D.; Drullinsky, P.; Gilewski, T.; Murphy, C.; Syldor, A.; Lau, A.; Hamilton, N.; Patil, S.; Liu, J.; Chandarlapaty, S.; Hudis, C.; Dang, C.
Abstract Title: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
Meeting Title: 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 72
Issue: 24 Suppl.
Meeting Dates: 2012 Dec 4-8
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2012-12-15
Language: English
ACCESSION: WOS:000209704901226
DOI: 10.1158/0008-5472.sabcs12-p5-18-20
PROVIDER: wos
Notes: Meeting Abstract: P5-18-20 -- Source: Wos
Altmetric Score
MSK Authors
  1. Sujata Patil
    383 Patil
  2. Jennifer Liu
    36 Liu
  3. Clifford Hudis
    840 Hudis
  4. Nancy T Sklarin
    46 Sklarin
  5. Chau Dang
    156 Dang
  6. Diana E Lake
    70 Lake
  7. Maura N Dickler
    237 Dickler
  8. Farrah Mikhail Datko
    8 Datko
  9. Monica Nancy Fornier
    136 Fornier
  10. Conleth Gerrard Murphy
    17 Murphy
  11. Devika Gajria
    23 Gajria
  12. Elizabeth Comen
    47 Comen
  13. Shanu Modi
    132 Modi
  14. Julie Fasano
    9 Fasano
  15. Angemael   Syldor
    4 Syldor
  16. Alan   Lau
    1 Lau